We are live on ! Find out more
WCM Investment Management

WCM Investment Management Portfolio holdings

AUM $43.8B
1-Year Est. Return 42.28%
This Fund
S&P 500
This Quarter Est. Return
+18.23%
1 Year Est. Return
+42.28%
3 Year Est. Return
+149.38%
5 Year Est. Return
+174.91%
10 Year Est. Return
+944.06%
AUM
$14.4B
AUM Growth
+$3.19B
Cap. Flow
+$1.19B
Cap. Flow %
8.25%
Top 10 Hldgs %
72.61%
Holding
149
New
70
Increased
62
Reduced
9
Closed
7

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$937M
2
RMD icon
ResMed
RMD
+$282M
3
NFLX icon
Netflix
NFLX
+$108M
4
ANSS
Ansys
ANSS
+$83.5M
5
SCHW
Charles Schwab
SCHW
+$70.1M

Top Sells

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$266M
2
CLB icon
Core Laboratories
CLB
+$121M
3
AMZN icon
Amazon
AMZN
+$106M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$85.2M
5
ACN icon
Accenture
ACN
+$7.8M

Sector Composition

Rank Sector Weight
1 Technology 30.82%
2 Financials 23.91%
3 Healthcare 23.08%
4 Industrials 12.77%
5 Energy 1.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YELP icon
126
Yelp
YELP
$1.41B
$775K 0.01%
+22,461
New +$812K
ARRY
127
DELISTED
Array Biopharma Inc
ARRY
$759K 0.01%
+31,140
New +$648K
RETA
128
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$752K 0.01%
+8,802
New +$731K
ORBC
129
DELISTED
ORBCOMM, Inc.
ORBC
$720K 0.01%
+106,275
New +$849K
SGRY icon
130
Surgery Partners
SGRY
$2.03B
$717K 0.01%
+63,547
New +$800K
WDAY icon
131
Workday
WDAY
$44.4B
$675K ﹤0.01%
3,500
INGN icon
132
Inogen
INGN
$164M
$609K ﹤0.01%
+6,383
New +$796K
CHRD icon
133
Chord Energy
CHRD
$7.39B
$591K ﹤0.01%
+97,811
New +$586K
HALO icon
134
Halozyme
HALO
$12.2B
$515K ﹤0.01%
+31,997
New +$518K
KYNB
135
Kyntra Bio
KYNB
$29.4M
$497K ﹤0.01%
+366
New +$496K
BHVN
136
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$461K ﹤0.01%
+8,950
New +$387K
HRTX icon
137
Heron Therapeutics
HRTX
$92.9M
$422K ﹤0.01%
+17,267
New +$452K
LGND icon
138
Ligand Pharmaceuticals
LGND
$6.36B
$359K ﹤0.01%
+4,575
New +$347K
ULTI
139
DELISTED
Ultimate Software Group Inc
ULTI
$343K ﹤0.01%
+1,040
New +$319K
SNPS icon
140
Synopsys
SNPS
$79.7B
$321K ﹤0.01%
+2,790
New +$276K
KURA icon
141
Kura Oncology
KURA
$850M
$320K ﹤0.01%
+19,288
New +$297K
NICE icon
142
Nice
NICE
$5.97B
$205K ﹤0.01%
+1,671
New +$188K
ACWX icon
143
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
-4,770
Closed -$200K
EFA icon
144
iShares MSCI EAFE ETF
EFA
$80.2B
-1,449,364
Closed -$85.2M
GIB icon
145
CGI
GIB
$15.5B
-3,410
Closed -$209K
HLIO icon
146
Helios Technologies
HLIO
$2.76B
-62,132
Closed -$2.06M
SONY icon
147
Sony
SONY
$138B
-20,990
Closed -$203K
VEU icon
148
Vanguard FTSE All-World ex-US ETF
VEU
$70.2B
-5,667
Closed -$258K
VSM
149
DELISTED
Versum Materials, Inc.
VSM
-227,495
Closed -$6.31M

Similar funds

WCM Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, WCM Investment Management held 149 positions worth $14.4B, up 28% from $11.2B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

WCM Investment Management deployed $1.19B of net new capital in Q1 2019, opening 70 new positions and adding to 62 existing holdings. Its largest new stake was Netflix: 3,111,450 shares worth $111M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Icon, an estimated $266M trimmed.

  • WCM Investment Management's largest Q1 2019 buy was Netflix: 3,111,450 shares worth $111M.
  • WCM Investment Management added most to Chubb in Q1 2019, an estimated $937M increase.
  • WCM Investment Management's biggest Q1 2019 reduction was Icon, cutting an estimated $266M.
  • WCM Investment Management fully exited iShares MSCI EAFE ETF in Q1 2019, selling an estimated $85.2M.
  • WCM Investment Management's ten largest holdings make up 73% of its $14.4B portfolio in Q1 2019.
  • WCM Investment Management opened 70 new positions and closed 7 in Q1 2019.
  • WCM Investment Management's portfolio value rose 28% quarter-over-quarter to $14.4B.

Based on WCM Investment Management's 13F filing for Q1 2019, filed 13 May 2019.